- Home
- KALA vs STEC Comparison
KALA vs STEC Comparison
Compare KALA & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- STEC
- Stock Information
- Founded
- KALA 2009
- STEC 2006
- Country
- KALA United States
- STEC China
- Employees
- KALA N/A
- STEC N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- STEC
- Sector
- KALA Health Care
- STEC
- Exchange
- KALA Nasdaq
- STEC NYSE
- Market Cap
- KALA 26.2M
- STEC 29.7M
- IPO Year
- KALA 2017
- STEC 2021
- Fundamental
- Price
- KALA $4.82
- STEC $0.89
- Analyst Decision
- KALA Strong Buy
- STEC
- Analyst Count
- KALA 3
- STEC 0
- Target Price
- KALA $14.00
- STEC N/A
- AVG Volume (30 Days)
- KALA 64.7K
- STEC 15.1K
- Earning Date
- KALA 08-05-2025
- STEC 07-07-2025
- Dividend Yield
- KALA N/A
- STEC N/A
- EPS Growth
- KALA N/A
- STEC N/A
- EPS
- KALA N/A
- STEC N/A
- Revenue
- KALA N/A
- STEC $10,672,000.00
- Revenue This Year
- KALA N/A
- STEC $9,392.20
- Revenue Next Year
- KALA N/A
- STEC N/A
- P/E Ratio
- KALA N/A
- STEC N/A
- Revenue Growth
- KALA N/A
- STEC N/A
- 52 Week Low
- KALA $2.92
- STEC $0.20
- 52 Week High
- KALA $11.20
- STEC $3.25
- Technical
- Relative Strength Index (RSI)
- KALA 55.88
- STEC 44.88
- Support Level
- KALA $4.36
- STEC $0.76
- Resistance Level
- KALA $5.90
- STEC $1.00
- Average True Range (ATR)
- KALA 0.48
- STEC 0.10
- MACD
- KALA 0.05
- STEC -0.01
- Stochastic Oscillator
- KALA 39.81
- STEC 32.25
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a customer based technology company. The company is engaged in exploring new opportunities in technology that includes new retail, social e-commerce, metaverse and others.